Organization

Nova Scotia Health Authority

10 clinical trials

1 abstract

Clinical trial
Intra-lesional ACE Inhibitor for Treatment of Hypertrophic Scars
Status: Not yet recruiting, Estimated PCD: 2026-08-01
Abstract
Population based assessment of HER-2 and PD-L1 positivity in gastric and gastroesophageal junction adenocarcinomas in a Canadian population.
Org: QEII Health Sciences Center, Research Methods Unit, Nova Scotia Health Authority, Queen Elizabeth II Health Sciences Centre/Capital Health,
Clinical trial
Lemborexant for Insomnia in a Patient With Dementia: An N-of-1 Trial
Status: Recruiting, Estimated PCD: 2028-12-11
Clinical trial
Onabotulinum Toxin A to Improve Direct Brow Lift Outcomes
Status: Active (not recruiting), Estimated PCD: 2024-07-01
Clinical trial
Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)
Status: Recruiting, Estimated PCD: 2028-12-31
Clinical trial
Histamine Receptor 2 Antagonists as Enhancers of Anti-Tumour Immunity
Status: Completed, Estimated PCD: 2018-10-24